Patents by Inventor Heidrun Schott

Heidrun Schott has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-PSGL-1 ANTIBODIES AND USES THEREOF
    Publication number: 20240124604
    Abstract: Provided herein, in one aspect, are antibodies that immunospecifically bind to PSGL-1, polynucleotides comprising nucleotide sequences encoding such antibodies, and expression vectors and host cells for producing such antibodies. Also provided herein are kits and pharmaceutical compositions comprising antibodies that specifically bind to PSGL-1, as well as methods of treating a disorder or disease caused by or associated with increased proliferation and/or numbers of activated T cells using the antibodies described herein.
    Type: Application
    Filed: December 26, 2023
    Publication date: April 18, 2024
    Applicant: AltruBio Inc.
    Inventors: Stefan Bassarab, Barbara Enenkel, Patrick Garidel, Heidrun Schott, Sanjaya Singh, Tobias Litzenburger
  • Anti-PSGL-1 antibodies and uses thereof
    Patent number: 11897964
    Abstract: Provided herein, in one aspect, are antibodies that immunospecifically bind to PSGL-1, polynucleotides comprising nucleotide sequences encoding such antibodies, and expression vectors and host cells for producing such antibodies. Also provided herein are kits and pharmaceutical compositions comprising antibodies that specifically bind to PSGL-1, as well as methods of treating a disorder or disease caused by or associated with increased proliferation and/or numbers of activated T cells using the antibodies described herein.
    Type: Grant
    Filed: August 30, 2021
    Date of Patent: February 13, 2024
    Assignee: AltruBio Inc.
    Inventors: Stefan Bassarab, Barbara Enenkel, Patrick Garidel, Heidrun Schott, Sanjaya Singh, Tobias Litzenburger
  • ANTI-PSGL-1 ANTIBODIES AND USES THEREOF
    Publication number: 20210395383
    Abstract: Provided herein, in one aspect, are antibodies that immunospecifically bind to PSGL-1, polynucleotides comprising nucleotide sequences encoding such antibodies, and expression vectors and host cells for producing such antibodies. Also provided herein are kits and pharmaceutical compositions comprising antibodies that specifically bind to PSGL-1, as well as methods of treating a disorder or disease caused by or associated with increased proliferation and/or numbers of activated T cells using the antibodies described herein.
    Type: Application
    Filed: August 30, 2021
    Publication date: December 23, 2021
    Applicant: AltruBio Inc.
    Inventors: Stefan Bassarab, Barbara Enenkel, Patrick Garidel, Heidrun Schott, Sanjaya Singh, Tobias Litzenburger
  • ANTI-PSGL-1 ANTIBODIES AND USES THEREOF
    Publication number: 20130251708
    Abstract: Provided herein, in one aspect, are antibodies that immunospecifically bind to PSGL-1, polynucleotides comprising nucleotide sequences encoding such antibodies, and expression vectors and host cells for producing such antibodies. Also provided herein are kits and pharmaceutical compositions comprising antibodies that specifically bind to PSGL-1, as well as methods of treating a disorder or disease caused by or associated with increased proliferation and/or numbers of activated T cells using the antibodies described herein.
    Type: Application
    Filed: April 17, 2013
    Publication date: September 26, 2013
    Applicant: ABGENOMICS COOPERATIEF U.A.
    Inventors: STEFAN BASSARAB, BARBARA ENENKEL, PATRICK GARIDEL, HEIDRUN SCHOTT, SANJAYA SINGH, TOBIAS LITZENBURGER
  • ANTI-PSGL-1 ANTIBODIES AND USES THEREOF
    Publication number: 20130209449
    Abstract: Provided herein, in one aspect, are antibodies that immunospecifically bind to PSGL-1, polynucleotides comprising nucleotide sequences encoding such antibodies, and expression vectors and host cells for producing such antibodies. Also provided herein are kits and pharmaceutical compositions comprising antibodies that specifically bind to PSGL-1, as well as methods of treating a disorder or disease caused by or associated with increased proliferation and/or numbers of activated T cells using the antibodies described herein.
    Type: Application
    Filed: June 12, 2012
    Publication date: August 15, 2013
    Applicant: AbGenomics Cooperatief U.A.
    Inventors: Stefan Bassarab, Barbara Enenkel, Patrick Garidel, Heidrun Schott, Sanjaya Singh, Tobias Litzenburger
  • ANTI-PSGL-1 ANTIBODIES AND USES THEREOF
    Publication number: 20130011391
    Abstract: Provided herein, in one aspect, are antibodies that immunospecifically bind to PSGL-1, polynucleotides comprising nucleotide sequences encoding such antibodies, and expression vectors and host cells for producing such antibodies. Also provided herein are kits and pharmaceutical compositions comprising antibodies that specifically bind to PSGL-1, as well as methods of treating a disorder or disease caused by or associated with increased proliferation and/or numbers of activated T cells using the antibodies described herein.
    Type: Application
    Filed: June 12, 2012
    Publication date: January 10, 2013
    Applicant: AbGenomics Cooperatief U.A.
    Inventors: Stefan Bassarab, Barbara Enenkel, Patrick Garidel, Heidrun Schott, Sanjaya Singh, Tobias Litzenburger